Our past successes have contributed to MedTech Outlook calling Lumendi Company of the Year. It is our first year to be sponsor at EndoSwiss 2019.

Patient experience can be defined as a construct that encompasses a range of interactions that patients have with the health […]

In Brief: The past few weeks we have been preparing for the 26th United European Gastroenterology (UEG) Week in Vienna. In […]

In medicine, gastrointestinal is focused on the digestive system and its disorders. Gastrointestinal surgery is also referred to as upper […]

Speed read In this blog entry we are keeping you posted about some exciting developments regarding our CE Marking. As […]

Speed read In this blog entry we discuss how four criteria matter for achieving success in the medical or other […]

Speed read  FDA: We are happy to let you know that the United States Food and Drug Administration (FDA) has given […]

Speed read FDA: We have received United States Food and Drug Administration (FDA) 510(k) clearance for the DiLumen C2, our […]

A short while back we published an entry about new video with our Chairman Dr. Peter Johann. In it Dr. Peter […]

In brief: We have not published new content for a while, but I thought this was a great opportunity to […]

In brief: This is a short review of our experience at the 25th UEG Week in Barcelona (October 28th – November […]

In brief: A short while back we had our first webinar for investors. It was conducted by our CEO and […]

In short.  Our team at Lumendi Ltd. has been strengthened by 3 new members. All three are highly respected professionals […]

In short.  Our medical adviscory board has been strengthened by two highly qualified experts. Both, are highly respected in the […]

In short This is our report about the SECOND convention Lumendi staff attended. It is also a first at having Lumendi […]

In short: We are getting our sales organization ramped up. Here we introduce you to some members of our sales team. […]

In short This is our report about the first convention Lumendi staff attended. We exhibited our DiLumen platform of products. This […]

In Short: Lumendi has hired Laurence Lefebvre to further strengthen the talent already working for Lumendi LLC. Lauranece will help […]

In Short: Jeffrey W. Milsom (Inventor), Peter Johann (CEO) and the Medical Advisory Board visited Japan this February. Here some […]

In Short: Lumendi is moving ever faster to get our products to market. Thanks to the 510(k) Clearance we got […]

In Short: Lumendi has hired 2 additional key members to further strengthen its team. Jim and Yukio will help us […]

In Short: Lumendi has an other important milestone. The company has received clearance from the US Food and Drug Administration […]

Summary. Lumendi staff and clinical advisory board were attending this year’s Digestive Disease Week 2016 at San Diego . DDW […]

Previously we introduced to you Mike Parrilla – Chief Operating Officer as well as as William Wick our CFO Today we […]

Previously we introduced to you Mike Parrilla – the Chief Operating Officer from Lumendi LCC Today we introduce to you […]

In our last blog entry you had the opportunity to read AND download our annual newsletter 2015. We stated that […]

  2015 was a great year This was a great year for Lumendi.  We concluded the license agreement with Weill […]

Update 2016-03-20 Find information about William Wick: CFO of Lumendi LCC In Kürze:Vor nicht allzu langer Zeit informierten wir sie […]

In Kürze: Lumendi LTD wächst. Aus diesem Grunde haben wir in den USA ein Tochterunternehmen gegründet – Lumendi LCC. Der […]

Download the 3-page press release from Cornell University.   Hier die Pressemitteilung der Cornell University zum Download – 4 Seiten. It’s official. […]

Zusammenfassung auf Deutsch gibt es weiter unten. Ebenfalls Slides zum Anschauen. Synopsis of our Lumendi Ltd. event, including slides for […]

On January 30, 2015 Lumendi has signed a worldwide exclusive license agreement for ESP and follow on products (ESP+/FAST) with […]